Will GENEDX HOLDINGS (WGS) Gain on Rising Earnings Estimates?

Core Viewpoint - GeneDx Holdings Corp. is experiencing a positive trend in earnings estimates, which is likely to continue driving its stock price upward [1][2]. Earnings Estimate Revisions - Analysts have shown growing optimism regarding GeneDx's earnings prospects, leading to a rising trend in estimate revisions that correlates with stock price movements [2]. - For the current quarter, the earnings estimate is $0.33 per share, reflecting a significant increase of +725.0% compared to the previous year [5]. - Over the past 30 days, two estimates for the current quarter have been revised upward, resulting in an 11.86% increase in the Zacks Consensus Estimate [5]. - For the full year, the earnings estimate stands at $1.60 per share, indicating a +540.0% change from the year-ago figure [6]. - The consensus estimate for the current year has risen by 21.61% due to the upward revisions [7]. Zacks Rank and Performance - GeneDx Holdings has achieved a Zacks Rank 1 (Strong Buy), indicating strong agreement among analysts in raising earnings estimates [8]. - Stocks with a Zacks Rank 1 and 2 are shown to significantly outperform the S&P 500 [8]. - Over the past four weeks, GeneDx shares have increased by 27.3%, suggesting investor confidence in its earnings growth prospects [9].